Back to search

Article

Advances in Single-Cell Sequencing Technology and its Applications in Triple-Negative Breast Cancer

2021-11-10

Abstract excerpt

Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer and is mainly treated with chemotherapy-based combination therapy. In recent years, the increasing development of single-cell sequencing (SCS) has become one of the most promising technologies in the field of biotechnology. The study of the heterogeneity of TNBC tumor cells using SCS will expand our current knowledge of metastasis...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
107684db-7fab-5a07-b138-cd974552b63a
DOI
10.21203/rs.3.rs-1034157/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Advances in Single-Cell Sequencing Technology and its Applications in Triple-Negative Breast CancerDOI 10.21203/rs.3.rs-1034157/v1
Select a neighboring publication to make it the new centre.